Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,244 | 4,760 | 7,100 | 7,804 | 4,841 |
| Receivables | 736 | 761 | 706 | 513 | 1,642 |
| TOTAL | $3,236 | $5,939 | $8,134 | $8,782 | $6,765 |
| Non-Current Assets | |||||
| PPE Net | 69 | 81 | 93 | 106 | 107 |
| Other Non-Current Assets | 1,344 | 1,406 | 1,485 | 1,558 | 1,633 |
| TOTAL | $1,413 | $1,487 | $1,578 | $1,664 | $1,740 |
| Total Assets | $4,649 | $7,426 | $9,712 | $10,446 | $8,505 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,264 | 1,886 | 1,876 | 1,194 | 1,514 |
| TOTAL | $2,616 | $2,229 | $2,210 | $1,520 | $1,831 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 989 | 1,081 | 1,171 | 1,257 | 1,341 |
| TOTAL | $989 | $1,081 | $1,171 | $1,257 | $1,341 |
| Total Liabilities | $3,605 | $3,310 | $3,381 | $2,777 | $3,172 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,263 | 13,787 | 13,786 | 13,784 | 10,259 |
| Common Shares | 13 | 13 | 13 | 13 | 10 |
| Retained earnings | -347,712 | -344,548 | -342,249 | -339,823 | -337,774 |
| TOTAL | $1,044 | $4,116 | $6,331 | $7,669 | $5,333 |
| Total Liabilities And Equity | $4,649 | $7,426 | $9,712 | $10,446 | $8,505 |